Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Array BioPharma reported revenue of $23.2m for the second quarter of fiscal 2012, up from revenue of $16.5 million for the same period in fiscal 2011.
Subscribe to our email newsletter
The net loss was significantly reduced to $3.8m for the second quarter, compared to a net loss of $12.4m for the second quarter in fiscal 2011.
The net loss improved due to increased revenue recognized from up-front and milestone payments during the current quarter.
The company reported revenue of $45.4m for the six-month period ended 31 December 2011, compared to revenue of $35.0m for the same period in fiscal 2011.
Net loss for the six months ended 31 December 2011 was $7.4m compared to a net loss of $23.1m for the corresponding period in fiscal 2011.